Uplyftt Membership Program require to change account password.



*
*
*
 

Note:
Password should contains atleast one capital letter one lowercase letter and one symbol and number and must be atleast 8 characters in length.

Human Growth Hormone Market Size & Analysis Report 2021-26

  • According to the latest report by IMARC Group, titled “Human Growth Hormone Market Size: Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026”, the global human growth hormone market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.2% during 2021-2026.

    Human growth hormone, also known as somatotropin or HGH, is a peptide hormone that regulates growth, reproduction, regeneration, repair and metabolism of cells. This hormone is secreted by the pituitary gland to stimulate growth in children and adults. The deficiency of HGH can be treated by administering recombinant HGH by subcutaneous injections.

    Human Growth Hormone (HGH) Market Report by Application (Growth Hormone (GH) Deficiency, Turner Syndrome, Idiopathic Short Stature (ISS), Prader-Willi Syndrome (PWS), Small for Gestational Age, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Route of Administration (Intravenous, Intramuscular, Subcutaneous, Oral), Key Players and Region – Global Industry Outlook to 2025.

    Request Free Sample Report: https://www.imarcgroup.com/human-growth-hormone-market/requestsample

    Market Trends

    The rising awareness regarding the efficacy of HGH in the treatment of various conditions represents one of the leading market drivers. For instance, HGH helps in controlling body composition and fluids, sugar and fat metabolism, muscle and bone growth, and recovering from injury among patients suffering from adult GH deficiency. Besides this, the increasing government initiatives to create awareness regarding the GH deficiencies and treatment acts as another significant driver. Moreover, the extensive investment in the research and development (R&D) activities for developing recombinant human growth hormones (rHGH) with fewer side effects and prolonged efficacy is also expected to provide a positive impact on the market in the upcoming years.

    Table of Contents

    1 Preface
    2 Scope and Methodology
    2.1 Objectives of the Study
    2.2 Stakeholders
    2.3 Data Sources
    2.3.1 Primary Sources
    2.3.2 Secondary Sources
    2.4 Market Estimation
    2.4.1 Bottom-Up Approach
    2.4.2 Top-Down Approach
    2.5 Forecasting Methodology
    3 Executive Summary
    4 Introduction
    4.1 Overview
    4.2 Key Industry Trends
    5 Global Human Growth Hormone Market
    5.1 Market Overview
    5.2 Market Performance
    5.3 Market Forecast
    6 Market Breakup by Application
    6.1 Growth Hormone (GH) Deficiency
    6.1.1 Market Trends
    6.1.2 Major Types
    6.1.2.1 Market Types
    6.1.2.2 Market Types
    6.1.3 Market Forecast
    6.2 Turner Syndrome
    6.2.1 Market Trends
    6.2.1 Market Forecast
    6.3 Idiopathic Short Stature (ISS)
    6.3.1 Market Trends
    6.3.1 Market Forecast
    6.4 Prader-Willi Syndrome (PWS)
    6.4.1 Market Trends
    6.4.1 Market Forecast
    6.5 Small for Gestational Age
    6.5.1 Market Trends
    6.5.1 Market Forecast
    6.6 Others
    6.6.1 Market Trends
    6.6.1 Market Forecast
    7 Market Breakup by Distribution Channel
    7.1 Hospital Pharmacy
    7.1.1 Market Trends
    7.1.2 Market Forecast
    7.2 Retail Pharmacy
    7.2.1 Market Trends
    7.2.2 Market Forecast
    7.3 Online Pharmacy
    7.3.1 Market Trends
    7.3.2 Market Forecast
    7.4 Others
    7.4.1 Market Trends
    7.4.2 Market Forecast
    8 Market Breakup by Route of Administration
    8.1 Intravenous
    8.1.1 Market Trends
    8.1.2 Market Forecast
    8.2 Intramuscular
    8.2.1 Market Trends
    8.2.2 Market Forecast
    8.3 Subcutaneous
    8.3.1 Market Trends
    8.3.2 Market Forecast
    8.4 Oral
    8.4.1 Market Trends
    8.4.2 Market Forecast
    9 Market Breakup by Region
    9.1 North America
    9.1.1 United States
    9.1.1.1 Market Trends
    9.1.1.2 Market Forecast
    9.1.2 Canada
    9.1.2.1 Market Trends
    9.1.2.2 Market Forecast
    9.2 Asia Pacific
    9.2.1 China
    9.2.1.1 Market Trends
    9.2.1.2 Market Forecast
    9.2.2 Japan
    9.2.2.1 Market Trends
    9.2.2.2 Market Forecast
    9.2.3 India
    9.2.3.1 Market Trends
    9.2.3.2 Market Forecast
    9.2.4 South Korea
    9.2.4.1 Market Trends
    9.2.4.2 Market Forecast
    9.2.5 Australia
    9.2.5.1 Market Trends
    9.2.5.2 Market Forecast
    9.2.6 Indonesia
    9.2.6.1 Market Trends
    9.2.6.2 Market Forecast
    9.2.7 Others
    9.2.7.1 Market Trends
    9.2.7.2 Market Forecast
    9.3 Europe
    9.3.1 Germany
    9.3.1.1 Market Trends
    9.3.1.2 Market Forecast
    9.3.2 France
    9.3.2.1 Market Trends
    9.3.2.2 Market Forecast
    9.3.3 United Kingdom
    9.3.3.1 Market Trends
    9.3.3.2 Market Forecast
    9.3.4 Italy
    9.3.4.1 Market Trends
    9.3.4.2 Market Forecast
    9.3.5 Spain
    9.3.5.1 Market Trends
    9.3.5.2 Market Forecast
    9.3.6 Russia
    9.3.6.1 Market Trends
    9.3.6.2 Market Forecast
    9.3.7 Others
    9.3.7.1 Market Trends
    9.3.7.2 Market Forecast
    9.4 Latin America
    9.4.1 Brazil
    9.4.1.1 Market Trends
    9.4.1.2 Market Forecast
    9.4.2 Mexico
    9.4.2.1 Market Trends
    9.4.2.2 Market Forecast
    9.4.3 Others
    9.4.3.1 Market Trends
    9.4.3.2 Market Forecast
    9.5 Middle East and Africa
    9.5.1 Market Trends
    9.5.2 Market Breakup by Country
    9.5.3 Market Forecast
    10 SWOT Analysis
    10.1 Overview
    10.2 Strengths
    10.3 Weaknesses
    10.4 Opportunities
    10.5 Threats
    11 Value Chain Analysis
    12 Porters Five Forces Analysis
    12.1 Overview
    12.2 Bargaining Power of Buyers
    12.3 Bargaining Power of Suppliers
    12.4 Degree of Competition
    12.5 Threat of New Entrants
    12.6 Threat of Substitutes
    13 Competitive Landscape
    13.1 Market Structure
    13.2 Key Players
    13.3 Profiles of Key Players
    13.3.1 Eli Lilly and Company (NYSE: LLY)
    13.3.1.1 Company Overview
    13.3.1.2 Product Portfolio
    13.3.1.3 Financials
    13.3.1.4 SWOT Analysis
    13.3.2 EMD Serono Inc.
    13.3.2.1 Company Overview
    13.3.2.2 Product Portfolio
    13.3.3 F. Hoffmann-La Roche AG
    13.3.3.1 Company Overview
    13.3.3.2 Product Portfolio
    13.3.3.3 SWOT Analysis
    13.3.4 Ferring B.V.
    13.3.4.1 Company Overview
    13.3.4.2 Product Portfolio
    13.3.4.3 Financials
    13.3.5 Genentech Inc.
    13.3.5.1 Company Overview
    13.3.5.2 Product Portfolio
    13.3.5.3 SWOT Analysis
    13.3.6 Ipsen
    13.3.6.1 Company Overview
    13.3.6.2 Product Portfolio
    13.3.6.3 Financials
    13.3.7 Merck KGaA
    13.3.7.1 Company Overview
    13.3.7.2 Product Portfolio
    13.3.7.3 Financials
    13.3.8 Novartis AG (SWX: NOVN)
    13.3.8.1 Company Overview
    13.3.8.2 Product Portfolio
    13.3.9 Novo Nordisk (CPH: NOVO-B)
    13.3.9.1 Company Overview
    13.3.9.2 Product Portfolio
    13.3.10 Pfizer Inc. (NYSE: PFE)
    13.3.10.1 Company Overview
    13.3.10.2 Product Portfolio
    13.3.10.3 Financials
    13.3.10.4 SWOT Analysis
    13.3.11 Sandoz
    13.3.11.1 Company Overview
    13.3.11.2 Product Portfolio

    Ask Analyst for Customization and Browse Full Report with TOC & List of Figure: https://www.imarcgroup.com/human-growth-hormone-market

    As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts, are being done after considering the impact of this pandemic.

    We are updating our reports, If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours.

    About Us

    IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

    IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

    Contact US

    IMARC Group
    30 N Gould St, Ste R
    Sheridan, WY (Wyoming) 82801 USA
    Email: Sales@imarcgroup.com
    Tel No:(D) +91 120 433 0800
    Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800